In this study we demonstrate that the elevation of Oct4A at the mRNA level correlates with the enhancement in TUBB2A, PLEC and VIM expression in parental HEY, SKOV3 and OVCAR5 ovarian cancer cell lines in response to paclitaxel or cisplatin treatments (Fig. 6). The gene discussed is VIM; the disease is ovarian carcinoma.